Affinity Capital Advisors
ABBV icon

Affinity Capital Advisors’s AbbVie ABBV Stock Holding History

Affinity Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.15M Buy
4,168
+408
+11% +$105K 0.13% 74
2026
Q2 		$958K Sell
3,760
-58
-2% -$12.5K 0.12% 76
2026
Q1 		$830K Sell
3,818
-187
-5% -$41.5K 0.12% 76
2025
Q4 		$915K Buy
4,005
+564
+16% +$128K 0.13% 74
2025
Q3 		$814K Buy
3,441
+8
+0.2% +$1.63K 0.13% 76
2025
Q2 		$637K Buy
3,433
+10
+0.3% +$1.86K 0.11% 84
2025
Q1 		$599K Buy
3,423
+4
+0.1% +$778 0.12% 81
2024
Q4 		$614K Buy
3,419
+9
+0.3% +$1.66K 0.12% 81
2024
Q3 		$673K Buy
3,410
+8
+0.2% +$1.49K 0.13% 84
2024
Q2 		$584K Sell
3,402
-25
-0.7% -$4.14K 0.12% 86
2024
Q1 		$624K Buy
3,427
+37
+1% +$6.38K 0.14% 78
2023
Q4 		$525K Sell
3,390
-55
-2% -$8.02K 0.13% 82
2023
Q3 		$514K Buy
3,445
+173
+5% +$25.4K 0.14% 83
2023
Q2 		$441K Buy
3,272
+53
+2% +$7.77K 0.12% 80
2023
Q1 		$513K Sell
3,219
-30
-0.9% -$4.59K 0.16% 75
2022
Q4 		$525K Buy
3,249
+6
+0.2% +$920 0.18% 62
2022
Q3 		$435K Buy
3,243
+5
+0.2% +$717 0.15% 66
2022
Q2 		$496K Sell
3,238
-43
-1% -$6.57K 0.17% 65
2022
Q1 		$532K Buy
3,281
+54
+2% +$7.84K 0.17% 65
2021
Q4 		$437K Buy
3,227
+1
+0% +$118 0.13% 74
2021
Q3 		$348K Buy
3,226
+1
+0% +$114 0.12% 84
2021
Q2 		$363K Buy
3,225
+236
+8% +$26.6K 0.12% 85
2021
Q1 		$323K Buy
+2,989
New +$320K 0.12% 86

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Affinity Capital Advisors's ABBV Position: Q3 2026 in Review

Affinity Capital Advisors increased its AbbVie (ABBV) stake by 11% in Q3 2026, buying an estimated $105K and bringing the position to 4,168 shares worth $1.15M. The position accounts for 0.13% of the portfolio, ranked #74.

Affinity Capital Advisors first reported a position in ABBV in Q1 2021 and has held it in 23 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Affinity Capital Advisors held 4,168 shares of AbbVie worth $1.15M as of Q3 2026.
  • Affinity Capital Advisors bought 408 AbbVie shares in Q3 2026, an estimated $105K.
  • AbbVie made up 0.13% of Affinity Capital Advisors's portfolio in Q3 2026, its #74 holding.
  • Affinity Capital Advisors first reported a position in AbbVie in Q1 2021 and has held it in 23 quarters since.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Affinity Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.